Our meta-analysis showed that urokinase-ApaLI (recessive model), VDR-ApaI (dominant model), and VDR-TaqI (heterozygous model) polymorphisms were significantly associated with decreased risk of recurrent kidney stones. The gene discussed is VDR; the disease is nephrolithiasis.